Safety of Cyclophosphamide Therapy in Autoimmune Rheumatic Diseases

Safety of Cyclophosphamide Therapy in Autoimmune Rheumatic Diseases

Cyclophosphamide (CYC) is one of the most potent antineoplastic and immunosuppressant agents. It is used as a drug of choice in many organ-threatening manifestations of systemic autoimmune rheumatic diseases (AIRDs) such as lupus nephritis, antineutrophil cytoplasmic antibody-associated vasculitis,...

Full description

Bibliographic Details
Main Authors: Ramaswamy Subramanian, Himanshu Pathak, Vinod Ravindran
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Indian Journal of Rheumatology
Subjects:
Cyclophosphamide
gonadal failure
hemorrhagic cystitis
immunosuppressants
lupus nephritis
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=2;spage=127;epage=135;aulast=Subramanian

Internet

http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=2;spage=127;epage=135;aulast=Subramanian

Similar Items